Research on the Audit Risk and Risk Prevention of Enterprise M&A—Take Huarun Pharmaceutical Company as an Example

Abstract

With the development of the times and economic, the construction of capital markets has gradually become mature, and more and more companies have chosen mergers and acquisitions (M&A) to seek development. Although M&A can make the enterprise scale and capital grow rapidly, its complexity and difficulty make the enterprise face all kinds of risks in this process. Among them, the most likely risk is to bring economic losses to the enterprise. This article takes China Huarun pharmaceutical company as an example to analyze the audit risks faced by the company during mergers and acquisitions. By studying the current status of mergers and acquisitions of the company, the audit risks are analyzed and corresponding prevention and control strategies are given. We hope that based on the theoretical basis of M&A audit risk, we will conduct research on the audit risks that may arise in transaction activities and propose countermeasures to reduce the overall audit risk to a controllable level. Research on the Audit Risk and Risk Prevention of Enterprise M&A—Take Huarun Pharmaceutical Company as an ExampleDownload